FolioLanternBeta
MAZEMaze Therapeutics, Inc.

Atul Dandekar

Csbo at Maze Therapeutics, Inc., as of Oct 1, 2026Sold $5.2M of stock in the past 12 months: 97% under a disclosed plan and 3% to cover taxes.

Updated Oct 16, 2026 from SEC filings · covers Oct 17, 2025 to Oct 16, 2026
146K
shares sold, past 12 months
13
days with sales
$2.9M
largest single day, Dec 29, 2025
1
company filed for

Share of stake sold and shares held at Maze Therapeutics, Inc. are being verified and not shown yet. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
OctNovDec 2025: $2.9M under a disclosed plan$2.9MDecJan 2026: $332K under a disclosed planJanFeb 2026: $341K under a disclosed planFebMar 2026: $220K under a disclosed planMarApr 2026: $190K under a disclosed planAprMay 2026: $198K under a disclosed planMayJun 2026: $210K under a disclosed planJunJul 2026: $205K under a disclosed planJulAug 2026: $207K under a disclosed planAugSep 2026: $203K under a disclosed planSep 2026: $169K to cover taxesSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Maze Therapeutics, Inc. (MAZE)CsboJan 30, 2025Oct 1, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.